title: The role of parenteral lipids in supporting gluconeogenesis in very premature infants.
abstract: We have previously demonstrated that very premature infants receiving glucose at 17 micromol/kg min plus appropriate supply of parenteral lipids (Intralipid) and amino acids (TrophAmine) maintained normoglycemia by glucose produced primarily via gluconeogenesis. The present study addressed the individual roles of parenteral lipids and amino acids in supporting gluconeogenesis. Fourteen premature infants (993 +/- 36 g 27 +/- 1 wk) (mean +/- SE) were studied for 8 h on d 5 +/- 1 of life. All infants were receiving standard TPN prior to the study. At start of study, the glucose infusion rate was decreased to approximately 17 micromol/kg min and either Intralipid (g + AA; n = 8) or TrophAmine (g + IL; n = 6) was discontinued. Data from 14 previously studied infants receiving glucose (approximately 17 micromol/kg min) + TrophAmine + Intralipid (g + AA + IL) are included for comparison. Gluconeogenesis was measured by [U-13 C]glucose, (g + AA) and (8 infants of the g + AA + IL group) or [2-13C]glycerol, (g + IL) and (6 infants of the g + AA + IL group). Infants studied by the same method were compared. Withdrawal of Intralipid resulted in decreased gluconeogenesis, 6.3 +/- 0.9 (g +AA) vs. 8.4 +/- 0.7 micromol/kg min (g + AA + IL) (p = 0.03). Withdrawal of TrophAmine affected neither total gluconeogenesis, 7.5 +/- 0.8 vs. 7.9 +/- 0.9 micromol/kg min nor gluconeogenesis from glycerol, 4.4 +/- 0.6 vs. 4.9 +/- 0.7 micromol/kg min (g+ IL and g + AA + IL groups, respectively). In conclusion, in parenterally fed very premature infants, lipids play a primary role in supporting gluconeogenesis.
authors.affiliation: Children's Nutrition Research Center, USDA/ARS, Baylor College of Medicine, Houston, TX 77030, USA. asunehag@bcm.tmc.edu
authors.forename: Agneta L
authors.initials: AL
authors.lastname: Sunehag
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage / Q000378:metabolism; D004573:Electrolytes; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage*; D005260:Female; D005865:Gestational Age; D005943:Gluconeogenesis / Q000502:physiology*; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D007223:Infant; D007225:Infant Food; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature; D007328:Insulin / Q000378:metabolism; D008297:Male; D010288:Parenteral Nutrition; D057947:Parenteral Nutrition Solutions; D011849:Radioactive Tracers; D012996:Solutions
chemical_list: D000596:Amino Acids; D004573:Electrolytes; D005217:Fat Emulsions, Intravenous; D007328:Insulin; D057947:Parenteral Nutrition Solutions; D011849:Radioactive Tracers; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; D006003:Glycogen; D005947:Glucose